Pulike Biological Engineering to abolish supervisory board, reports Q3 revenue rise

Pulike Biological Engineering will hold an Extraordinary General Meeting on November 27, 2025, to approve amendments to its Articles of Association and governance structures. These changes include the elimination of the Supervisory Board, with its functions to be assumed by the Board of Directors' Audit Committee. The company also announced revisions to its Articles of Association, the rules of procedure for the Shareholders' Meeting and Board of Directors, and various internal policies.

These proposed governance updates coincide with the release of Pulike Biological Engineering’s Q3 2025 report. For the first nine months of 2025, the company reported an operating income of CNY 823,012,660.74, an 8.04% increase year-over-year. Net profit attributable to shareholders reached CNY 157,135,240.20, marking a 47.86% increase compared to the same period last year. Total assets remained stable at CNY 3,091,165,680.19. The company also announced a Q3 earnings webcast for December 1, 2025.